Opus Genetics, Inc.
IRD
$3.61
-$0.11-2.96%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -9.14% | -699.79% | 52.97% | -131.92% | 4.44% |
| Total Depreciation and Amortization | 0.00% | 0.00% | 30.00% | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -8,738.18% | 10,292.10% | -74.87% | 1,237.92% | -106.82% |
| Change in Net Operating Assets | 135.43% | 65.31% | -94.82% | -45.92% | -743.24% |
| Cash from Operations | -16.37% | -41.51% | -32.20% | -20.02% | -40.83% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 3,400.00% | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -53.27% | -- | 1,048.90% | -100.00% |
| Repurchase of Common Stock | -- | 8.33% | -213.51% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1,223.40% | -102.55% | -113.04% | -575.73% | -327.27% |
| Cash from Financing | 4,414.68% | 34.84% | 29,146.99% | 1,186.97% | -41.17% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 409.23% | 29.61% | 326.21% | 66.21% | -62.78% |